{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T17:45:25Z","timestamp":1790531125220,"version":"4.1.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2020,11,3]],"date-time":"2020-11-03T00:00:00Z","timestamp":1604361600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"European Union\u2014European Federation of Pharmaceutical Industries and Associations"},{"name":"Innovative Medicines Initiatives 2 Joint Undertaking","award":["115952"],"award-info":[{"award-number":["115952"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,7,13]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background and Objectives<\/jats:title>\n                  <jats:p>The meaning of Alzheimer\u2019s disease (AD) is changing in research. It now refers to a pathophysiological process, regardless of whether clinical symptoms are present. In the lay literature, on the other hand, AD is understood as a form of dementia. This raises the question of whether researchers and the lay audience are still talking about the same thing. If not, how will these different understandings of AD shape perspectives on (societal) needs for people with AD?<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Research Design and Methods<\/jats:title>\n                  <jats:p>We use framing analysis to retrieve the understandings of the term AD that are upheld in the research literature and in national Dutch newspaper articles. We make explicit how the framings of AD steer our normative attitudes toward the disease.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the analyzed research articles, AD is framed as a pathological cascade, reflected by biomarkers, starting in cognitively healthy people and ending, inevitably, in dementia. In the lay literature, AD is used as a synonym for dementia, and an AD diagnosis is understood as an incentive to enjoy \u201cthe time that is left.\u201d<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Discussion and Implications<\/jats:title>\n                  <jats:p>The two different uses of the term AD in research and in the lay literature may result in misunderstandings, especially those research framings that falsely imply that people with AD biomarkers will inevitably develop dementia. Adoption of the research understanding of AD in clinical practice will have normative implications for our view on priority setting in health care. For example, it legitimizes biomarker testing in people without dementia as improving \u201cdiagnostic\u201d certainty.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/geront\/gnaa113","type":"journal-article","created":{"date-parts":[[2020,8,19]],"date-time":"2020-08-19T11:25:28Z","timestamp":1597836328000},"page":"746-755","source":"Crossref","is-referenced-by-count":25,"title":["The Framing of \u201cAlzheimer\u2019s Disease\u201d: Differences Between Scientific and Lay Literature and Their Ethical Implications"],"prefix":"10.1093","volume":"61","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4502-6293","authenticated-orcid":false,"given":"Marthe","family":"Smedinga","sequence":"first","affiliation":[{"name":"Department of Medical Ethics and Philosophy and History of Medicine, Erasmus MC, Rotterdam, The Netherlands"},{"name":"Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eline M","family":"Bunnik","sequence":"additional","affiliation":[{"name":"Department of Medical Ethics and Philosophy and History of Medicine, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edo","family":"Richard","sequence":"additional","affiliation":[{"name":"Department of Neurology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maartje H N","family":"Schermer","sequence":"additional","affiliation":[{"name":"Department of Medical Ethics and Philosophy and History of Medicine, Erasmus MC, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,11,3]]},"reference":[{"issue":"3","key":"2021071312125738600_CIT0001","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Albert","year":"2011","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"2021071312125738600_CIT0002","author":"Alzheimer Europe","year":"2017"},{"key":"2021071312125738600_CIT0003","first-page":"143","article-title":"The return of the living dead, agency lost and found?","volume-title":"Dementia: Mind, meaning and person","author":"Aquilina","year":"2006"},{"issue":"1","key":"2021071312125738600_CIT0004","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1017\/S0144686X10000693","article-title":"The living dead? The construction of people with Alzheimer\u2019s disease as zombies","volume":"31","author":"Behuniak","year":"2011","journal-title":"Ageing & Society"},{"issue":"1","key":"2021071312125738600_CIT0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11019-009-9223-x","article-title":"Molecular medicine and concepts of disease: The ethical value of a conceptual analysis of emerging biomedical technologies","volume":"13","author":"Boenink","year":"2010","journal-title":"Medicine, Health Care, and Philosophy"},{"issue":"1","key":"2021071312125738600_CIT0006","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1057\/s41292-017-0065-0","article-title":"Gatekeeping and trailblazing: The role of biomarkers in novel guidelines for diagnosing Alzheimer\u2019s disease","volume":"13","author":"Boenink","year":"2018","journal-title":"Biosocieties"},{"key":"2021071312125738600_CIT0007","doi-asserted-by":"crossref","DOI":"10.1017\/CBO9781139173865.023","article-title":"Metaphor and theory change.","volume-title":"Metaphor and thought","author":"Boyd","year":"1993","edition":"2nd ed."},{"issue":"12","key":"2021071312125738600_CIT0008","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1136\/medethics-2018-104772","article-title":"On the personal utility of Alzheimer\u2019s disease-related biomarker testing in the research context","volume":"44","author":"Bunnik","year":"2018","journal-title":"Journal of Medical Ethics"},{"issue":"3","key":"2021071312125738600_CIT0009","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1207\/s15327027hc1903_9","article-title":"The case of the missing person: Alzheimer\u2019s disease in mass print magazines 1991\u20132001","volume":"19","author":"Clarke","year":"2006","journal-title":"Health Communication"},{"key":"2021071312125738600_CIT0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1057\/978-1-137-54097-3_10","article-title":"Dikes and dementia: How multiple framings of dementia coexist during the development of a national dementia strategy.","volume-title":"Emerging technologies for diagnosing Alzheimer\u2019s disease","author":"Cuijpers","year":"2016"},{"issue":"8","key":"2021071312125738600_CIT0011","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/S1474-4422(07)70178-3","article-title":"Research criteria for the diagnosis of Alzheimer\u2019s disease: Revising the NINCDS-ADRDA criteria","volume":"6","author":"Dubois","year":"2007","journal-title":"The Lancet. Neurology"},{"issue":"6","key":"2021071312125738600_CIT0012","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease: The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"The Lancet. Neurology"},{"issue":"3","key":"2021071312125738600_CIT0013","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer\u2019s disease: Definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"4","key":"2021071312125738600_CIT0014","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1460-2466.1993.tb01304.x","article-title":"Framing: Toward clarification of a fractured paradigm","volume":"43","author":"Entman","year":"1993","journal-title":"Journal of Communication"},{"key":"2021071312125738600_CIT0015","author":"European Medicines Agency","year":"2018"},{"key":"2021071312125738600_CIT0016","first-page":"209","article-title":"The role of the concept of Alzheimer disease in the development of the Alzheimer\u2019s Association in the United States.","volume-title":"The concept of Alzheimer\u2019s disease: Biological, clinical, and cultural perspectives","author":"Fox","year":"2000"},{"issue":"8","key":"2021071312125738600_CIT0017","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/S1474-4422(17)30159-X","article-title":"Strategic roadmap for an early diagnosis of Alzheimer\u2019s disease based on biomarkers","volume":"16","author":"Frisoni","year":"2017","journal-title":"The Lancet. Neurology"},{"issue":"1","key":"2021071312125738600_CIT0018","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1177\/1471301212451382","article-title":"The war (on terror) on Alzheimer\u2019s","volume":"13","author":"George","year":"2014","journal-title":"Dementia (London),"},{"issue":"1","key":"2021071312125738600_CIT0019","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2217\/nmt.12.75","article-title":"Should we disclose amyloid imaging results to cognitively normal individuals?","volume":"3","author":"Grill","year":"2013","journal-title":"Neurodegenerative Disease Management"},{"issue":"8","key":"2021071312125738600_CIT0020","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1002\/gps.5132","article-title":"Development of memory clinics in The Netherlands over the last 20 years","volume":"34","author":"Gruters","year":"2019","journal-title":"International Journal of Geriatriatric Psychiatry"},{"issue":"1","key":"2021071312125738600_CIT0021","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s13195-015-0112-7","article-title":"Development of a process to disclose amyloid imaging results to cognitively normal older adult research participants","volume":"7","author":"Harkins","year":"2015","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"2021071312125738600_CIT0022","author":"Harvard School of Public Health and Alzheimer Europe","year":"2011"},{"issue":"4","key":"2021071312125738600_CIT0023","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA Research Framework: Toward a biological definition of Alzheimer\u2019s disease","volume":"14","author":"Jack","year":"2018","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"2021071312125738600_CIT0024","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"The Lancet. Neurology"},{"issue":"19","key":"2021071312125738600_CIT0025","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1001\/jama.2015.4668","article-title":"Prevalence of cerebral amyloid pathology in persons without dementia: A meta-analysis","volume":"313","author":"Jansen","year":"2015","journal-title":"Journal of the American Medical Association"},{"issue":"1","key":"2021071312125738600_CIT0026","doi-asserted-by":"crossref","first-page":"e-1","DOI":"10.1016\/j.jalz.2013.01.002","article-title":"Appropriate use criteria for amyloid PET: A report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer\u2019s Association","volume":"9","author":"Johnson","year":"2013","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"2021071312125738600_CIT0027","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.socscimed.2015.08.031","article-title":"The relative contributions of disease label and disease prognosis to Alzheimer\u2019s stigma: A vignette-based experiment","volume":"143","author":"Johnson","year":"2015","journal-title":"Social Science & Medicine (1982)"},{"issue":"1","key":"2021071312125738600_CIT0028","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11019-016-9747-9","article-title":"The usual suspects: Why techno-fixing dementia is flawed","volume":"20","author":"Jongsma","year":"2017","journal-title":"Medicine, Health Care, and Philosophy"},{"issue":"4","key":"2021071312125738600_CIT0029","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/ppar\/prz020","article-title":"Time for a new strategy in the war on Alzheimer\u2019s disease","volume":"29","author":"Kaeberlein","year":"2019","journal-title":"Public Policy & Aging Report"},{"issue":"8","key":"2021071312125738600_CIT0030","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0378-2166(02)00187-X","article-title":"Scientific metaphors going public","volume":"35","author":"Knudsen","year":"2003","journal-title":"Journal of Pragmatics"},{"key":"2021071312125738600_CIT0031","volume-title":"Metaphors we live by","author":"Lakoff","year":"1980"},{"issue":"2","key":"2021071312125738600_CIT0032","doi-asserted-by":"crossref","first-page":"e0229137","DOI":"10.1371\/journal.pone.0229137","article-title":"Cognitively unimpaired adults\u2019 reactions to disclosure of amyloid PET scan results","volume":"15","author":"Largent","year":"2020","journal-title":"PLoS One"},{"key":"2021071312125738600_CIT0033","doi-asserted-by":"crossref","first-page":"f5125","DOI":"10.1136\/bmj.f5125","article-title":"Political drive to screen for pre-dementia: Not evidence based and ignores the harms of diagnosis","volume":"347","author":"Le Couteur","year":"2013","journal-title":"BMJ"},{"key":"2021071312125738600_CIT0034","doi-asserted-by":"crossref","first-page":"275","DOI":"10.14361\/9783839427101-013","article-title":"Dementia in the making: Early detection and the body\/brain in Alzheimer\u2019s disease.","volume-title":"Popularizing dementia, public expressions and representations of forgetfulness","author":"Leibing","year":"2015"},{"key":"2021071312125738600_CIT0035","doi-asserted-by":"crossref","DOI":"10.23943\/princeton\/9780691149783.001.0001","volume-title":"The Alzheimer conundrum: Entanglements of dementia and aging","author":"Lock","year":"2013"},{"issue":"7","key":"2021071312125738600_CIT0050","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"issue":"2","key":"2021071312125738600_CIT0036","first-page":"125","article-title":"Ethical issues in the development of readiness cohorts in Alzheimer\u2019s disease research","volume":"4","author":"Milne","year":"2017","journal-title":"The Journal of Prevention of Alzheimer\u2019s Disease"},{"issue":"1","key":"2021071312125738600_CIT0037","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1001\/jamaneurol.2017.2954","article-title":"Comprehension of an elevated amyloid positron emission tomography biomarker result by cognitively normal older adults","volume":"75","author":"Mozersky","year":"2018","journal-title":"JAMA Neurology"},{"issue":"2","key":"2021071312125738600_CIT0038","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41582-018-0116-6","article-title":"A critical appraisal of amyloid-beta-targeting therapies for Alzheimer disease","volume":"15","author":"Panza","year":"2019","journal-title":"Nature Reviews Neurology"},{"issue":"3","key":"2021071312125738600_CIT0039","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1212\/WNL.0000000000004826","article-title":"Practice guideline update summary: Mild cognitive impairment: Report of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology","volume":"90","author":"Petersen","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"2021071312125738600_CIT0040","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1155\/2009\/609839","article-title":"Amyloid imaging in aging and dementia: Testing the amyloid hypothesis in vivo","volume":"21","author":"Rabinovici","year":"2009","journal-title":"Behavioural Neurology"},{"issue":"6","key":"2021071312125738600_CIT0041","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-002541","article-title":"MRI and cerebrospinal fluid biomarkers for predicting progression to Alzheimer\u2019s disease in patients with mild cognitive impairment: a diagnostic accuracy study","volume":"3","author":"Richard","year":"2013","journal-title":"BMJ open"},{"issue":"1","key":"2021071312125738600_CIT0052","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/bioe.12516","article-title":"On the reconceptualization of Alzheimer\u2019s disease","volume":"33","author":"Schermer","year":"2019","journal-title":"Bioethics"},{"issue":"3","key":"2021071312125738600_CIT0042","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"Sperling","year":"2011","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"228","key":"2021071312125738600_CIT0043","doi-asserted-by":"crossref","first-page":"228fs13","DOI":"10.1126\/scitranslmed.3007941","article-title":"The A4 study: Stopping AD before symptoms begin?","volume":"6","author":"Sperling","year":"2014","journal-title":"Science Translational Medicine"},{"issue":"2","key":"2021071312125738600_CIT0044","doi-asserted-by":"crossref","first-page":"e16782","DOI":"10.1371\/journal.pone.0016782","article-title":"Metaphors we think with: The role of metaphor in reasoning","volume":"6","author":"Thibodeau","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"2021071312125738600_CIT0045","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.socscimed.2011.12.045","article-title":"Frames and counter-frames giving meaning to dementia: A framing analysis of media content","volume":"74","author":"Van Gorp","year":"2012","journal-title":"Social Science & Medicine (1982)"},{"issue":"11","key":"2021071312125738600_CIT0046","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1016\/j.jalz.2019.07.003","article-title":"Assessment of the appropriate use criteria for amyloid PET in an unselected memory clinic cohort: The ABIDE project","volume":"15","author":"de Wilde","year":"2019","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"s1","key":"2021071312125738600_CIT0047","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.3233\/JAD-179905","article-title":"The end of the beginning of the Alzheimer\u2019s disease nightmare: A devil\u2019s advocate\u2019s view","volume":"64","author":"Wimo","year":"2018","journal-title":"Journal of Alzheimer\u2019s Disease"},{"issue":"2","key":"2021071312125738600_CIT0048","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/geront\/gns203","article-title":"Dementia as a cultural metaphor","volume":"54","author":"Zeilig","year":"2013","journal-title":"The Gerontologist"}],"container-title":["The Gerontologist"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/gerontologist\/article-pdf\/61\/5\/746\/38934107\/gnaa113.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/gerontologist\/article-pdf\/61\/5\/746\/38934107\/gnaa113.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,13]],"date-time":"2021-07-13T12:15:32Z","timestamp":1626178532000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/gerontologist\/article\/61\/5\/746\/5952566"}},"subtitle":[],"editor":[{"given":"Barbara J","family":"Bowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,11,3]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2020,11,3]]},"published-print":{"date-parts":[[2021,7,13]]}},"URL":"https:\/\/doi.org\/10.1093\/geront\/gnaa113","relation":{},"ISSN":["0016-9013","1758-5341"],"issn-type":[{"value":"0016-9013","type":"print"},{"value":"1758-5341","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,8,1]]},"published":{"date-parts":[[2020,11,3]]}}}